# Left Atrial Volume and Phasic Function Assessed by 4D Auto LAQ Echocardiography in Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus Patients Without Hypertension or Obesity

**Authors:** Lin Li, Miao Li, Hong Ran, Ling-Ling Fang, Qian-Shan Ding, Ping-Yang Zhang

PMC · DOI: 10.3390/jcdd13030131 · Journal of Cardiovascular Development and Disease · 2026-03-10

## TL;DR

Newly diagnosed type 2 diabetes patients show early heart changes detectable with 4D echocardiography, suggesting a sensitive method for early diabetic heart disease detection.

## Contribution

4D Auto LAQ echocardiography reveals early left atrial dysfunction in treatment-naive type 2 diabetes patients.

## Key findings

- T2DM patients had increased left atrial volumes and impaired reservoir and conduit functions.
- HbA1c and E/e’ ratio independently correlate with left atrial strain parameters in diabetic patients.
- 4D Auto LAQ echocardiography detects early diabetic atrial myopathy in newly diagnosed patients.

## Abstract

(1) Background: Our aim was to evaluate left atrial (LA) volumes and function in patients with newly diagnosed, treatment-naive type 2 diabetes mellitus (T2DM) using Four-Dimensional Automated Left Atrial Quantificative (four-dimensional auto LAQ) analysis and to explore the independent factors influencing left atrial function in diabetic patients. (2) Method: A total of 62 treatment-naive, newly diagnosed T2DM patients without hypertension or obesity and 50 healthy controls were prospectively enrolled in the study. All participants underwent laboratory analyses, routine echocardiography and 4D LAQ assessment. The parameters were compared between the two groups, and independent factors influencing left atrial function in diabetic patients were investigated through univariate and multivariate linear regression analyses. (3) Results: Despite no significant difference in LA end-systolic anteroposterior diameter between groups, LA volume parameters (LAVmax, LAVmin, LAVpreA, and LAVmaxI) were significantly increased in T2DM patients (all p < 0.05). Regarding LA strain, reservoir and conduit function were significantly impaired in T2DM patients, as reflected by lower LASr, LAScd, LASr-c, and LAScd-c (all p < 0.05). Conversely, circumferential contractile strain (LASct-c) was significantly higher in the T2DM group (p = 0.029), while longitudinal contractile strain (LASct) did not differ significantly between groups (p = 0.146). Multivariate analysis revealed that HbA1c and E/e’ ratio were independently associated with multiple LA strain parameters (all p < 0.05). (4) Conclusion: Newly diagnosed, treatment-naive patients with T2DM exhibited increased LA volumes, decreased left atrial ejection fraction (LAEF), and impaired reservoir and conduit functions, accompanied by a compensatory increase in contractile function. Furthermore, HbA1c and E/e’ demonstrated an independent correlation with 4D strain parameters. 4D Auto LAQ echocardiography may serve as a sensitive tool for early detection of diabetic atrial myopathy.

## Linked entities

- **Diseases:** type 2 diabetes mellitus (MONDO:0005148)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** diabetic atrial myopathy (MESH:C564026), myocardial infarction (MESH:D009203), atrial fibrillation (MESH:D001281), atrial myopathy (MESH:D009135), fibrosis (MESH:D005355), overweight (MESH:D050177), underweight (MESH:D013851), Hypertension (MESH:D006973), hypertrophy (MESH:D006984), asthma (MESH:D001249), diabetic cardiomyopathy (MESH:D058065), heart failure (MESH:D006333), hyperglycemia (MESH:D006943), LA dysfunction (MESH:D018487), kidney failure (MESH:D051437), liver cirrhosis (MESH:D008103), valvular disease (MESH:D006349), congenital heart disease (MESH:D006330), injury to (MESH:D014947), atrial dysfunction (MESH:C538261), stroke (MESH:D020521), Obesity (MESH:D009765), T2DM (MESH:D003924), cardiac dysfunction (MESH:D006331), systole (MESH:D000092244), neoplastic disease (MESH:D004194), dilatation (MESH:D002311), LA impairment (MESH:D059446), cardiovascular disease (MESH:D002318), coronary artery disease (MESH:D003324), atrial (MESH:D064752), DM (MESH:D003920), chronic obstructive pulmonary disease (MESH:D029424), microvascular damage (MESH:D017566)
- **Chemicals:** creatinine (MESH:D003404), metformin (MESH:D008687), TC (MESH:D013667), glucose (MESH:D005947), CREA (-), cholesterol (MESH:D002784), TG (MESH:D013866), triglycerides (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A1C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026548/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026548/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026548/full.md

---
Source: https://tomesphere.com/paper/PMC13026548